Factors predicting the rate of functional progression in early and suspected glaucoma

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 3598-3604

  Gardiner, Stuart K ^a   Johnson, Chris A ^b   Demirel, Shaban ^a  

^a DEVERS EYE INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; OPTIC DISK CUP; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PREDICTION; PRIORITY JOURNAL; RETINAL NERVE FIBER LAYER THICKNESS; TONOMETRY; VISUAL ACUITY; VISUAL FIELD; AGED; COMPARATIVE STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; INTRAOCULAR HYPERTENSION; MALE; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; OPTIC DISK; PATHOPHYSIOLOGY; PROGNOSIS; TIME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMOSCOPY; OPTIC DISK; PROGNOSIS; TIME FACTORS; TONOMETRY, OCULAR; VISUAL ACUITY; VISUAL FIELDS;

EID: 84865650738     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-9065     Document Type: Article

References (51)

1. Kass MA, Gordon MO, Gao F, et al. Delaying treatment of ocular hypertension: The Ocular Hypertension Treatment Study. Arch Ophthalmol. 2010;128:276-287.
2. Heijl A, Lindgren G, Olsson J. Test retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108: 130-135.
3. Piltz J, Starita R. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1990;109:109-110.
4. Henson D, Chaudry S, Artes P, Faragher E, Ansons A. Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci. 2000;41:417-421.
5. Spry P, Johnson C, McKendrick A, Turpin A. Variability components of standard automated perimetry and frequency- doubling technology perimetry. Invest Ophthalmol Vis Sci. 2001;42:1404-1410.
6. McKean-Cowdin R, Varma R, Wu J, Hays RD, Azen SP. Los Angeles Latino Eye Study Group. Severity of visual field loss and health-related quality of life. Am J Ophthalmol. 2007;143: 1013-1023.
7. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: The Los Angeles Latino Eye Study. Ophthalmology. 2008;115:941-948.e941.
8. Anderson D, Patella V. Automated Static Perimetry. 2 ed. St. Louis, MO: Mosby; 1999:147-159.
9. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48-56.
10. Nouri-Mahdavi K, Hoffman D, Coleman A, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627-1635.
11. Gordon M, Beiser J, Brandt J, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 714-720.
12. Friedman D, Wilson M, Liebmann J, Fechtner R, Weinreb R. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol. 2004;138:19-31.
13. Hong S, Seong G, Hong Y. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol. 2007;125:1010-1013.
14. Broman A, Quigley H, West S, et al. Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci. 2008;49:66-76.
15. Drance S, Anderson D, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699-708.
16. Bengtsson B, Leske M, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114:205-209.
17. Johnson C, Cioffi G, Liebmann J, Sample P, Zangwill L, Weinreb R. The relationship between structural and functional alterations in glaucoma: a review. Seminars in Ophthalmology. 2000;15:221-233.
18. Artes P, Chauhan B. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res. 2005;24:333-354.
19. Chauhan B, McCormick T, Nicolela M, LeBlanc R. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol. 2001;119:1492-1499.
20. Keltner JL, Johnson CA, Anderson DR, et al. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology. 2006;113:1603-1612.
21. Alencar LM, Zangwill LM, Weinreb RN, et al. A comparison of rates of change in neuroretinal rim area and retinal nerve fiber layer thickness in progressive glaucoma. Invest Ophthalmol Vis Sci. 2010; Published ahead of print.
22. Gardiner S, Demirel S. Assessment of patient opinions of different clinical tests used in the management of glaucoma. Ophthalmology. 2008;115:2127-2131.
23. Zangwill LM, Weinreb RN, Beiser JA, et al. Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2005;123: 1188-1197.
24. Gardiner S, Johnson C, Demirel S. Cup size predicts subsequent functional change in early glaucoma. Optom Vis Sci. 2011;88:1470-1476.
25. Caprioli J. The importance of rates in glaucoma. Am J Ophthalmol. 2008;145:191-192.
26. Gardiner SK, Demirel S, Johnson CA. Perimetric indices as predictors of future glaucomatous functional change. Optom Vis Sci. 2011;88:56-62.
27. Kass M, Heuer D, Higginbotham E, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
28. Investigators. AGIS. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429-440.
29. Nouri-Mahdavi K, Hoffman D, Gaasterland D, Caprioli J. Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci. 2004;45:4346-4351.
30. Caprioli J, Coleman AL. Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology. 2008;115:1123-1129.
31. Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I. Intercurrent factors associated with the development of openangle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol. 2007;144:266-275.
32. Bengtsson B, Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefe's Arch Clin Exp Ophthalmol. 2005;243:513-518.
33. Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology. 1999;106:997-1004.
34. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134-142.
35. Burgoyne CF, Fortune B, Wang L, Downs JC, Gardiner SK. Intraocular pressure magnitude and fluctuation as predictors of rates of structural change in non human primate experimental glaucoma. (E-Abstract). Invest Ophthalmol Vis Sci. 2011;52:658.
36. Gardiner SK, Johnson CA, Cioffi GA. Evaluation of the structure-function relationship in glaucoma. Invest Ophthalmol Vis Sci. 2005;46:3712-3717.
37. Spry P, Johnson C, Mansberger S, Cioffi G. Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma. 2005;14:11-18.
38. Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol. 1997;75:368-375.
39. Fingeret M, Flanagan J, Lieberman J. (eds). The Heidelberg Retina Tomograph II Primer. Heidelberg, Germany: Heidelberg Engineering; 2005.
40. Bell BA, Ferron JM, Kromrey JD. Cluster size in multilevel models: the impact of sparse data structures on point and interval estimates in two-level models. Power. 2008;1122-1129.
41. Liang H, Wu H, Zou GA. Note on conditional AIC for linear mixed-effects models. Biometrika. 2008;95:773-778.
42. Steiger J. Tests for comparing elements of a correlation matrix. Psychological Bulletin. 1980;87:245-251.
43. Downs J, Burgoyne C, Liang Y, Sallee VA. New implantable system for telemetric IOP monitoring in nonhuman primates (NHP). Invest Ophthalmol Vis Sci. 2008;49:E-Abstract 2043.
44. Olthoff CMG, Schouten JSAG, van de Borne BW, Webers CAB. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology. 2005;112:953-961.
45. Hood DC, Raza AS, de Moraes CGV, et al. Initial arcuate defects within the central 10 degrees in glaucoma. Invest Ophthalmol Vis Sci. 2011;52:940-946.
46. Henson D, Artes P, Chauhan B. Diffuse loss of sensitivity in early glaucoma. Invest Ophthalmol Vis Sci. 1999;40:3147-3151.
47. Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46:4600-4606.
48. Artes PH, Chauhan BC, Keltner JL, et al. Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2010;128:1528-1532.
49. Grewal DS, Sehi M, Greenfield DS. Diffuse glaucomatous structural and functional damage in the hemifield without significant pattern loss. Arch Ophthalmol. 2009;127:1442-1448.
50. Bengtsson B, Heijl AA. Visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145: 343-353.
51. Artes PH, Chauhan BC. Properties of the Statpac visual field index (VFI) (E-Abstract). Invest Ophthalmol Vis Sci. 2010;51: 5494.